| Jangka masa | Harga Ramalan | lalu | Bersejarah | Wawasan |
|---|---|---|---|---|
| Esok | $26.80 ▲ +1.59% | Semalam | $26.20 ▼ -0.67% | Tomorrow's Summit Therapeutics Inc. Common Stock (SMMT) setup is anchored to $26.38 and targets $26.80 (+1.59%). The near-term read is upside; watch $27.17 / $25.59 because daily realized volatility is about 8.00%. |
Tomorrow's Summit Therapeutics Inc. Common Stock (SMMT) setup is anchored to $26.38 and targets $26.80 (+1.59%). The near-term read is upside; watch $27.17 / $25.59 because daily realized volatility is about 8.00%. | ||||
| Minggu | $27.69 ▲ +4.95% | Minggu lepas | $25.83 ▼ -2.08% | The 7-day Summit Therapeutics Inc. Common Stock model moves from $25.83 to $27.69 (+4.95%). It gives upside momentum context for this stock, so breaks around $27.17 / $25.59 matter more than a single tick. |
The 7-day Summit Therapeutics Inc. Common Stock model moves from $25.83 to $27.69 (+4.95%). It gives upside momentum context for this stock, so breaks around $27.17 / $25.59 matter more than a single tick. | ||||
| bulan | $29.16 ▲ +10.54% | Bulan lepas | $25.21 ▼ -4.43% | The 1-month Summit Therapeutics Inc. Common Stock target is $29.16 (+10.54%), compared with the live reference near $26.38. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Summit Therapeutics Inc. Common Stock target is $29.16 (+10.54%), compared with the live reference near $26.38. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| tahun | $31.37 ▲ +18.93% | Tahun lepas | $24.28 ▼ -7.95% | The 1-year Summit Therapeutics Inc. Common Stock scenario points to $31.37 (+18.93%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Summit Therapeutics Inc. Common Stock scenario points to $31.37 (+18.93%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Tahun | $36.56 ▲ +38.57% | 5 Tahun Lalu | $22.11 ▼ -16.20% | The 5-year Summit Therapeutics Inc. Common Stock view is $36.56 (+38.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Summit Therapeutics Inc. Common Stock view is $36.56 (+38.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Penunjuk | Nilai | Isyarat |
|---|---|---|
| Price | $26.38 | Mid |
| Daily Change | +5.02% | Above |
| Volatility Cap | 20.0% | Mid |
| Confidence | 68% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $26.38 | Daily Change | +5.02% |
| Market Cap | $20.47B | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.